Drug Trial Radar · NCT00003369
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
Last checked: Nov 19, 2026Latest source record: Jun 14, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
56
Actual
Start
Aug 1998
Primary completion
Oct 2003
Study completion Jul 2004
Sponsor
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jun 24, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of tirapazamine plus cisplatin in treating patients who have metastatic, recurrent, or refractory cervical cancer.
Conditions
- Cervical Cancer
Interventions
cisplatinDrug
75 mg/m2 IV as a one-hour infusion after tirapazamine on Day 1 of each 21-day cycle
tirapazamineDrug
260 mg/m2 over two hours prior to cisplatin on Day 1 of each 21-day cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- overall survivalTime frame: 6 months
Locations
85 sites in 1 country. Site status is shown where the registry gives one.
MBCCOP - University of South Alabama
Mobile, Alabama
CCOP - Greater Phoenix
Phoenix, Arizona
Veterans Affairs Medical Center - Phoenix (Hayden)
Phoenix, Arizona
Veterans Affairs Medical Center - Tucson
Tucson, Arizona
Arizona Cancer Center
Tucson, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Veterans Affairs Medical Center - Little Rock (McClellan)
Little Rock, Arkansas
Veterans Affairs Medical Center - Long Beach
Long Beach, California
USC/Norris Comprehensive Cancer Center
Los Angeles, California
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California
Beckman Research Institute, City of Hope
Los Angeles, California
Veterans Affairs Outpatient Clinic - Martinez
Martinez, California
CCOP - Bay Area Tumor Institute
Oakland, California
Chao Family Comprehensive Cancer Center
Orange, California
University of California Davis Medical Center
Sacramento, California
UCSF Cancer Center and Cancer Research Institute
San Francisco, California
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California
David Grant Medical Center
Travis Air Force Base, California
Veterans Affairs Medical Center - Denver
Denver, Colorado
University of Colorado Cancer Center
Denver, Colorado
CCOP - Atlanta Regional
Atlanta, Georgia
Dwight David Eisenhower Army Medical Center
Fort Gordon, Georgia
Cancer Research Center of Hawaii
Honolulu, Hawaii
CCOP - Central Illinois
Decatur, Illinois
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)
Hines, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Kansas Medical Center
Kansas City, Kansas
CCOP - Wichita
Wichita, Kansas
Veterans Affairs Medical Center - Wichita
Wichita, Kansas
Veterans Affairs Medical Center - Lexington
Lexington, Kentucky
Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky
MBCCOP - LSU Medical Center
New Orleans, Louisiana
Tulane University School of Medicine
New Orleans, Louisiana
Veterans Affairs Medical Center - New Orleans
New Orleans, Louisiana
Louisiana State University Health Sciences Center - Shreveport
Shreveport, Louisiana
Veterans Affairs Medical Center - Shreveport
Shreveport, Louisiana
Boston Medical Center
Boston, Massachusetts
Veterans Affairs Medical Center - Boston (Jamaica Plain)
Jamaica Plain, Massachusetts
Veterans Affairs Medical Center - Ann Arbor
Ann Arbor, Michigan
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
Showing 40 of 85 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.